Agarwal Writing Aids Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.26 M
- Company Age 29 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.00 M
- Revenue Growth 27.15%
- Profit Growth 24.61%
- Ebitda 51.60%
- Net Worth 6.82%
- Total Assets -3.55%
About Agarwal Writing Aids
Agarwal Writing Aids Pvt Ltd (AWAPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 December 1995 and has a history of 29 years and two months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.26 M.
The company currently has active open charges totaling ₹9.00 M.
Binod Agarwal and Vijay Agarwal serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51109WB1995PTC076172
- Company No.
076172
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Dec 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Agarwal Writing Aids?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Binod Agarwal  | Director | 26-Dec-1995 | Current |
| Vijay Agarwal | Director | 26-Dec-1995 | Current |
Financial Performance of Agarwal Writing Aids.
Agarwal Writing Aids Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 27.15% increase. The company also saw a substantial improvement in profitability, with a 24.61% increase in profit. The company's net worth moved up by a moderate rise of 6.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agarwal Writing Aids?
In 2022, Agarwal Writing Aids had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹9.00 M
₹0
Charges Breakdown by Lending Institutions
- United Bank Of India : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Feb 2013 | United Bank Of India | ₹5.00 M | Open |
| 18 May 2009 | United Bank Of India | ₹4.00 M | Open |
How Many Employees Work at Agarwal Writing Aids?
Unlock and access historical data on people associated with Agarwal Writing Aids, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agarwal Writing Aids, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agarwal Writing Aids's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
